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Effects of c-Myc overexpression on the DNA damage-induced G2/M checkpoint were studied in finite lifespan, normal human
mammary epithelial cells (HMECs). Previously, we showed that c-Myc attenuates G1/S arrest and leads to an inappropriate entry of
cells with damaged DNA into the S phase, following treatment with ionising radiation (IR). Here we show that, in striking contrast to
control cells, c-Myc-overexpressing HMECs demonstrate a significant attenuation of the G2/M arrest, following IR, and enter into
inappropriate mitoses. At the molecular level, ectopic overexpression of c-Myc leads to an unusually high level of expression of cyclin
B1, and the elevated levels of cyclin B1 were maintained, after g-irradiation. Introduction of DNA damage in c-Myc-overexpressing,
normal mammary epithelial cells eventually induces apoptosis, indicating a dramatic sensitisation by c-Myc of DNA damage-induced
apoptosis. These two remarkable phenotypes, checkpoint attenuation and sensitisation to apoptosis, resulting from a deregulation of
the protooncogene c-myc, may produce a unique pattern of alternating cycles, consisting first of amplification of DNA damage,
followed by apoptosis-assisted selective pressure. The result of this alternating pattern of damage apoptosis could facilitate the
selection of certain genomic alterations required for cellular survival and cellular transformation.
British Journal of Cancer (2003) 89, 1479–1485. doi:10.1038/sj.bjc.6601307 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: c-Myc; DNA damage; ionising radiation; G2/M checkpoint; cyclin B1; human mammary epithelial cells
                                           
In response to DNA damage, cells arrest primarily at the G1/S and
G2/M boundaries (Hartwell et al, 1994; Kastan, 2001). G1/S arrest
blocks entry of damaged DNA into the S phase, and G2/M arrest
prohibits entry of damaged DNA into mitosis. Therefore, both G1/
S and G2/M checkpoints are important for maintaining genomic
stability, an essential requirement for the fidelity of transmission
of intact genomes to cellular progeny (Hartwell, 1992; Paulovich
et al, 1997). The G2/M checkpoint appears to be established
through two distinct steps: immediate establishment of the
checkpoint, and maintenance of prolonged arrest (Taylor and
Stark, 2001). The eventual target of the G2/M-entry checkpoint is
the mitotic kinase, Cdc2-cyclin B, which governs most of the
processes involved in mitotic initiation and progression (Murray
and Hunt, 1993). In response to DNA damage, cells prevent the
activation of Cdc2-cyclin B through various mechanisms, includ-
ing cytoplasmic sequestration of critical components for Cdc2
activation (cyclin B and Cdc25C), transactivation of the cyclin-
dependent kinase inhibitor (CKI) p21/Cip1, and transrepression of
Cdc2 and cyclin B (Bunz et al, 1998; Taylor et al, 1999; Graves et al,
2001). For initial establishment of the G2/M checkpoint, elimina-
tion of the Cdc25C protein phosphatase activity appears to be a
critical step (Peng et al, 1997; Sanchez et al, 1997; Zeng and
Piwnica-Worms, 1999; Graves et al, 2001; Zhao and Piwnica-
Worms, 2001). A well-known tumour suppressor, p53 protein, has
also been demonstrated to participate in the maintenance of the
G2/M checkpoint. p53-defective cells fail to maintain the DNA
damage-induced arrest, and gradually escape the checkpoint and
progress into the M phase, when they eventually undergo aberrant
mitoses (Bunz et al, 1998). For this p53-mediated checkpoint
arrest, p53 may exert its functions via transactivation of its target
genes, such as p21/Cip1, GADD45, 14-3-3s, or via transrepression
of cdc2 and cyclin B1 genes (el-Deiry et al, 1994; Hermeking et al,
1997; Bunz et al, 1998; Taylor et al, 1999; Wang et al, 1999).
Therefore, once activated by the DNA damage signal, p53 blocks
Cdc2-cyclin B kinase activity to prevent completely the entry of
damaged chromosomes into mitosis.
In a previous study with normal human mammary epithelial
cells (HMECs), we have shown that overexpression of the
protooncogene c-myc significantly attenuates the DNA damage-
induced G1/S arrest, suggesting that deregulated c-Myc predis-
poses normal cells to genomic instability (Sheen and Dickson,
2002). In addition, we also identified the formation of micronuclei,
selectively in cells with excess c-Myc activity, following a
prolonged interval, post-treatment with ionising radiation (IR).
These micronuclei result from aberrant mitoses, following various
types of deleterious stresses to cells (Forrester et al, 1999, 2000).
Depending on the cell line and the nature of the damage, the
resulting mitoses are aberrant and incomplete, skipping a proper
segregation of chromosomes and cytokinesis. These abortive
mitoses eventually produce multiple micronuclei, which are
completely, or partially, separated from each other (Forrester
et al, 1999, 2000). Although their underlying mechanisms are not
fully understood, the aberrant mitoses can be induced not only by
DNA damage but also by inappropriate activation of Cdc2-cyclin B
mitotic kinase (Heald et al, 1993), suggesting that micronuclei are Received 3 March 2003; revised 22 July 2003; accepted 24 July 2003
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These aberrant mitoses also suggest that an abrogation of G2/M-
entry checkpoint precedes the micronucleation. Based on these
ideas, we hypothesised that the overexpression of c-Myc may alter
the G2/M arrest, following DNA damage, leading to an inap-
propriate entry of damaged chromosomes into mitosis.
RESULTS
Overexpression of c-Myc has no effect on the overall time-
course of the nocodazole-induced mitotic arrest
To measure cellular entry into mitosis from the G2 phase, we
employed the mitotic-arrest assay (Bunz et al, 1998). Cells arrest in
mitosis, following treatment with a microtubule (MT) destabiliser
(e.g. colchicine or nocodazole) because the drug destroys an MT-
based mitotic spindle that is essential for mitosis. When DNA
damage is introduced, normal cells, however, do not arrest in
mitosis, even in the presence of MT destabiliser. Instead, they
arrest at G2/M because of the DNA damage-induced checkpoint.
However, cells defective in their G2/M checkpoint should produce
mitotic cells, following DNA damage, which undergo inappropriate
entry into mitosis. Therefore, one can test the intactness of DNA
damage-induced G2/M checkpoint by measuring mitotic figures,
following the introduction of DNA damage, in the presence of MT
destabiliser. One condition of this mitotic-arrest assay would be
that experimental populations should arrest in mitosis over the
same time-course following the MT destabiliser treatment. In other
words, all samples should possess a similarly effective spindle-
assembly checkpoint that monitors the intactness of mitotic
spindle assembly and governs mitotic progress.
We initially tested the effects of c-Myc on the MT destabiliser-
induced spindle assembly checkpoint, by measuring mitotic
figures with the MPM-2 marker, following treatment of nocoda-
zole. MPM-2, a mitosis-specific marker (Davis et al, 1983), has
been used to identify mitotic cells with rounded-up morphology
and condensed chromosomes, representative characteristics of
mitosis (Figure 1B). In independently repeated experiments, both
retroviral vector (LXSN)-infected control cells and c-Myc-infected
cells displayed mitotic arrest over the same time-course, following
nocodazole treatment (Figure 1A and C). After prolonged arrest in
mitosis, cells appeared to adapt to the absence of a mitotic spindle
and escaped from mitosis. This is consistent with the previously
reported ‘mitotic slippage’ phenomena following cellular treatment
with mitotic spindle inhibitors (Schimke et al, 1991, 1994).
Overexpression of c-Myc attenuates the DNA damage-
induced G2/M-entry checkpoint
In asynchronous populations, with a certain percentage (B15–
20%) of cells in G2, both LXSN-infected control cells and Myc-
infected cells displayed a positive index of MPM-2, indicating
mitosis at a frequency of 4–5% (Figure 2A and B). The
introduction of DNA damage (10Gy of g-irradiation) led LXSN-
infected controls to decrease their mitotic index dramatically, and
led irradiated cells to display almost no mitotic cells. In contrast, c-
Myc-infected cells regained a mitotic index (B4%) that is
comparable to the untreated population at the 24h time-point,
following an initial decrease at the 12h time-point. Following 24h,
c-Myc-overexpressing cells progressively decreased their mitotic
index. This attenuated DNA damage-induced G2/M arrest, in c-
Myc-overexpressing cells, was even more evident, following the
introduction of DNA damage in the presence of the MT
destabiliser (nocodazole) (Figure 2A and B). LXSN-infected
controls consistently displayed a decreased mitotic index, follow-
ing g-irradiation, regardless of nocodazole treatment. However, in
the presence of nocodazole-mediated mitotic arrest, c-Myc-
infected cells showed an increasing frequency of MPM-2-positive
mitotic figures, following g-irradiation, and reached a peak at 36h
time-point (Figure 2A).
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Figure 1 c-Myc has no effect on the time-course of nocodazole-induced
mitotic arrest of normal HMECs. Following an infection with LXSN vector-
only or c-Myc retroviruses, cells were allowed to express exogenous genes
for 48h. (A) Cells were treated with nocodazole, an MT destabiliser, and
their degree of arrest in mitosis (%MPM-2 positive) was measured over a
time-course of 0, 8, 16, 24, 32, and 40h time-points. Both LXSN-infected
controls (filled circle) and c-Myc-overexpressing cells (nonfilled circle)
arrested at mitosis over the same time-course, following artificial abrogation
of mitotic spindles. (B) DAPI staining identifies mitotic cells, with typical,
condensed chromosomes. Rounded-up cells, on phase-contrast micro-
scopy, match with cells having condensed chromosomes on DAPI staining.
Finally, mitotic cells were confirmed with a mitosis-specific marker, MPM-2.
(C) Representative figures demonstrate gradual changes of MPM-2-positive
mitotic cells, following prolonged treatment with nocodazole.
DNA damage-induced G2/M arrest by c-Myc
J-H Sheen et al
1480
British Journal of Cancer (2003) 89(8), 1479–1485 & 2003 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
yCells with deregulated c-Myc display high levels of cyclin
B1 before and after c-irradiation
To gain insights into the molecular mechanism(s) for the c-Myc-
mediated attenuation of the G2/M checkpoint, we measured
changes in the levels of proteins that are implicated in the G2/M
transition, over a time-course, following IR (Figure 3). After
transient expression of c-Myc in normal HMECs for 48h, cells
were immediately irradiated with 10Gy IR, and cell lysates were
prepared. The ectopic expression of c-Myc led cells to express
higher levels of p53 and p21 proteins, even in the absence of DNA
damage, and made them more responsive to the DNA damage. On
the other hand, consistent with previous studies in our group
(Sheen and Dickson, 2002), transient expression of c-Myc did not
inhibit or arrest the cell cycle progression of normal HMECs. It
consistently led to a cell cycle profile characterised by a lower
percentage of G1 and a higher percentage of S, when compared to
that of LXSN-infected controls. Significantly, we identified
surprisingly high levels of cyclin B1 protein in normal HMECs
overexpressing c-Myc, and these upregulated levels were main-
tained for a period of time, even after DNA damage (Figure 3). As
we also identified high levels of the Cdc2 kinase itself in c-Myc-
overexpressing cells, we wanted to determine whether c-Myc
controls expression of these critical G2/M genes at the mRNA level
or at a post-mRNA level. In assays employing a cDNA microarray,
we were able to detect a markedly high level of cyclin B1 (CCNB1)
gene transcripts (Table 1). We also detected a marginally higher
level of Cdc2 transcripts.
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Figure 2 Overexpression of c-Myc attenuates DNA damage-induced G2/M arrest. To investigate the G2/M transition, after DNA damage, cells were
irradiated with 10Gy, and MPM2-positive cells were measured over a time-course. (A) Irradiated LXSN-infected controls (filled circle) and c-Myc-
overexpressing cells (nonfilled circle) were stained with MPM2 in the absence or presence of nocodazole. Note the different scale of the y-axis (mitotic
index) in the two graphs. (B) Representative figures, showing a gradual increase of MPM2-positive ones, selectively in irradiated c-Myc-overexpressing cells.
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DNA damage-induced apoptosis
In our experiments using a mitotic-arrest assay to study the G2/M
transition, we frequently identified condensed nuclei, which are
stained with DAPI, but not with MPM-2, following DNA damage
(Figure 2B). Therefore, we wanted to determine if these condensed
nuclei indicate apoptotic cells, by staining with an antibody against
cleaved PARP. Full-length PARP proteins are cleaved during the
apoptosis process. Following a prolonged incubation after IR-
induced DNA damage, putative apoptotic nuclei, with fragmented
chromosomes, were identified selectively in c-Myc-overexpressing
cells; the apoptotic phenotype of these cells was confirmed with
staining for cleaved PARP (Figure 4). Based on these results, we
concluded that c-Myc-overexpressing cells are selectively sensitive
to the DNA damage-induced apoptosis.
Table 1 cDNA array analysis of changes in gene expression, following IR
Gene name LXSN-0h LXSN-10h LXSN-20h MYC-0h MYC-10h MYC-20h
Bax 1.00 1.60 1.56 2.85 2.18 2.76
Cyclin B 1.00 1.49 0.98 3.60 2.32 2.71
Cyclin D1 1.00 1.84 1.80 1.14 0.79 0.91
Cyclin D2 1.00 0.95 1.22 1.33 1.19 1.44
Cdk1 (cdc2) 1.00 1.15 0.67 1.54 1.59 1.63
Cdk2 1.00 0.56 0.49 1.52 1.40 2.44
Cdk4 1.00 0.73 0.60 0.97 1.20 1.22
p53 1.00 0.47 1.79 0.45 1.63 0.73
p21/Cip1 1.00 1.82 1.39 1.57 1.99 2.05
p16ink4 1.00 0.63 0.55 1.07 0.77 0.82
p19Ink4d 1.00 1.35 0.97 0.72 1.15 0.81
GADD45 1.00 1.34 1.27 1.35 0.98 1.89
Mdm2 1.00 1.71 1.77 2.01 2.86 4.54
Human cell-cycle GEArrayt Q series kit was used to identify changes in mRNA levels following g-irradiation. Fold differences in mRNA levels to the control group (HMEC-
LXSN) were calculated. The GEArray data were quantitated with the ImageQuaNTt software and analysed with the GEArray analyzert 1.2 software. Background signals were
processed with minimal value and positive signals were normalised with the median value. IR¼ionising radiation.
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Figure 3 Overexpression of c-Myc upregulates cyclin B1 and results in
an inappropriately high level of cyclin B1, following DNA damage. Western
blotting analysis of c-Myc, p53, cyclin B1, Cdc2, and p21/Cip1 in normal
HMECs over a time-course, following 10Gy g-irradiation. a-tubulin blots
serve the equal loading control.
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Figure 4 c-Myc-overexpressing cells are sensitive to DNA damage-
induced apoptosis. DNA damage eventually induces apoptosis of c-Myc-
overexpressing cells. (A) A time-course change in the percentage of
apoptotic cells was measured with Hoechst 33258 and cleaved PARP
staining. (B) Representative figures, showing apoptotic cells with
fragmented DNA, in Hoechst 33258 staining and with cleaved PARP.
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According to a recent study of c-myc ( / ) rat fibroblasts, the
absence of c-Myc prolongs both G1 and G2, suggesting a role for c-
Myc in the G2/M transition (Mateyak et al, 1999). Furthermore, we
previously showed that some cells, with deregulated c-Myc activity,
replicated their damaged templates and ended up in post-M phase
with multiple micronuclei, which suggests the possibility that
deregulated c-Myc attenuates the DNA damage-induced G2/M
checkpoint (Sheen and Dickson, 2002).
We employed the mitotic-arrest assay to measure G2/M entry,
following DNA damage (Bunz et al, 1998). One critical condition
for the mitotic-arrest assay is that all sample groups should have
the same kinetics of mitotic arrest and escape from the arrest,
following nocodazole treatment, because the nocodazole-induced
chemical blockage is not complete. Cells eventually adapt to this
nocodazole challenge and escape to a state, termed ‘G1-like post-M
phase’, with interphase morphology with micronuclei (‘mitotic
slippage’ phenotype) (Schimke et al, 1991, 1994). Therefore, we
first demonstrated that both control LXSN- and c-Myc-infected
normal HMECs have the same kinetics of mitotic arrest and
escape, following nocodazole treatment (Figure 1). At the same
time, our results also provided a clue on how MT destabiliser
induces polyploidy in c-Myc-overexpressing cells. As c-Myc-
overexpressing cells did not escape, any faster than control cells
from the nocodazole-induced mitotic-arrest, deregulated c-Myc
has no effects on the spindle-assembly checkpoint, suggesting the
possibility of c-Myc’s effects selectively on the post-M checkpoint.
Similarly, p53-deficient cells have a normal spindle-assembly
checkpoint and an altered post-M checkpoint (Lanni and Jacks,
1998; Li and Dang, 1999).
We irradiated unsynchronised populations in order to avoid any
effects of artificial synchronisation on the cell cycle of normal
HMECs. Following IR, the empty vector control cells (HMEC-
LXSN) displayed a dramatic reduction of mitoses, regardless of
nocodazole treatment. However, in surprising contrast, c-Myc-
overexpressing cells showed a significant number of mitotic cells
after g-irradiation. The effects were even clearer in the presence of
nocodazole (Figure 2A and B). We interpreted these results to
indicate that c-Myc attenuates G2/M arrest, following DNA
damage, and that the cells undergoing inappropriate mitoses were
arrested in M phase.
In Western analyses, we demonstrated that cyclin B1 and Cdc2,
two components of the cyclin B1/Cdc2 mitotic kinase complex, are
significantly upregulated, following a transient overexpression of
c-Myc in normal HMECs. The upregulated levels of cyclin B1 and
Cdc2 were maintained, even after DNA damage, until they
eventually began to decrease (Figure 3). Next, the markedly high
level of cyclin B1 mRNA transcripts was identified in a cDNA array
analysis (Table 1). A previous study reported the effects of
overexpression of cyclin B1 mutants on the DNA damage-induced
G2/M checkpoint in HeLa cells (Jin et al, 1998). In this report, the
overexpression of wild-type cyclin B1 was initially considered
insufficient to attenuate G2/M arrest, following DNA damage.
However, in the presence of nocodazole, its effects were
significantly demonstrated (Jin et al, 1998). In the current study,
we showed a significantly attenuated G2/M arrest in c-Myc-
overexpressing HMECs that coincidently have upregulated levels
of cyclin B1.
The overexpression of c-Myc alone was not sufficient to induce
premature mitosis; this may be primarily because the inhibitory
phosphorylations of Cdc2 are independently regulated (Jin et al,
1996). However, we cannot rule out a possible role of the c-Myc-
mediated alteration of G2/M arrest in c-Myc-induced genomic
instability. The high-fidelity performance of mitosis is extremely
critical for an accurate segregation of genetic materials and for the
maintenance of genomic stability. Presumably, the unprepared
entry into mitosis, such as what may occur during premature
mitosis, may produce a significant amount of genomic damage.
However, severe genomic damage would be fatal and cells
sustaining such damage from premature mitosis may not survive.
On the other hand, attenuated control over the G2/M arrest, which
is still unsatisfactory for the precise segregation of genes, could be
barely tolerable for cell survival, such that cells containing
genomic alterations could survive.
In addition to observing a checkpoint alteration, we found that
normal HMECs with c-Myc overexpression eventually undergo
apoptosis, following DNA damage, indicating that deregulated
c-Myc sensitises cells to apoptosis (Figure 4). The parental,
normal HMECs were resistant to the DNA damage-induced
apoptosis, presumably because of the arrest of their cell cycle.
Although c-Myc has been known to induce apoptosis under
cellular stresses, such as growth factor deprivation, we currently do
not fully understand as to how c-Myc sensitises cells or what
triggers apoptosis in c-Myc-overexpressing cells, after DNA
damage.
As shown in Figure 3, c-Myc slightly upregulates p53, and c-
Myc-overexpressing cells rapidly respond to DNA damage by
inducing p21/Cip1, suggesting the possibility of heightened
p53 activity and p53-mediated apoptosis of c-Myc-overexpressing
cells. This hypothesis would be compatible with a c-Myc-mediated
checkpoint attenuation phenotype, if c-Myc modulates or
redirects p53 toward apoptosis, rather than toward cell cycle
arrest. An alternative hypothesis would be that abrogation of
cell cycle arrest precedes apoptosis. In p21( / ) human colon
carcinoma cells, the elimination of p21 makes the cells dramati-
cally susceptible to DNA damage-induced apoptosis, compared to
the parental cells (Waldman et al, 1996). In a pilot experiment,
however, we failed to rescue c-Myc-overexpressing cells from
apoptosis, following DNA damage, with an induced cell cycle
arrest. Instead, we observed that induction of artificial arrest
of cell cycle, with excess thymidine or Purvalanol, led to apoptosis
of c-Myc-overexpressing HMECs (data not shown). The
prior reports showed that c-Myc-overexpressing fibroblasts are
highly apoptotic when cell cycles are artificially perturbed (Evan
et al, 1992). Therefore, future studies, focusing on molecular
mechanisms for c-Myc-induced checkpoint alteration and sensi-
tisation to apoptosis, are required to determine how the two
remarkable Myc phenotypes are related in terms of different c-Myc
target genes.
MATERIALS AND METHODS
Cell culture and retroviral infection
Normal, finite lifespan HMECs (#1001-12, CC-2551) at passage 7,
originally derived from reduction mammoplasty tissues, were
obtained from BioWhittaker, Inc. (Walkersville, MD, USA), and
cells between passage 8 and 10 were used for experiments. Normal
HMECs were maintained according to the supplier’s instructions
in mammary epithelial cell growth medium (MEGM, CC-3152),
supplemented with 52mgml
 1 bovine pituitary extract, 10ngml
 1
human EGF, 5mgml
 1 insulin, and 0.5mgml
 1 hydrocortisone,
and were grown in 371C incubators with low (0.1–0.2%) CO2
settings. Transient overexpression of c-myc was performed with
pLXSN-Myc as previously described (Sheen and Dickson, 2002).
Briefly, cells were plated 1 day before retroviral infection at B70%
confluency. Transient infection was conducted with recombinant
retroviruses, at an MOI of 3–5. Following 12h of infection,
in the presence of 8mgml
 1 polybrene, and 48h of gene
expression, infected cells were utilised for experiments, without
further selection in G418. For the mitotic-arrest assay, culture
media were replaced, following g-irradiation, with fresh media,
containing nocodazole (0.15mgml
 1), and cells were further
incubated.
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DNA damage was induced by IR, using a
137Cs source g-irradiator
(JL Shepherd Mark-I Irradiator, San Fernando, CA, USA), at a rate
of 3.6Gymin
 1, until the specified, absorbed dosage was reached.
For irradiation of attached cells, cells were plated in culture dishes
on Day 1, and irradiated at 70–80% confluency on Day 2. All
experimental samples in dishes were kept rotating on a turntable,
inside the irradiator machine, during the irradiation procedure.
Immunocytochemistry
Mitotic cells were monitored by staining with MPM-2, a mitosis-
specific marker. After g-irradiation, cells were plated on glass cover
slips in prewarmed media in 12-well culture plates. A total of
5 10
4 cells were plated per well and then allowed to grow in the
presence or absence of nocodazole. At each time-point, cells were
washed three times with PBS (10min each wash) and fixed in 4%
paraformaldehyde/PBS for 20min. Next, the fixed cells were
permeabilised with 0.5% Triton X-100/PBS. Following incubation
with an anti-MPM-2 monoclonal antibody (10mgml
 1, Upstate
Biotech, Waltham, MA, USA), cells were washed three times with
PBS and the nuclei were counterstained with 40,60-diamidino-2-
phenylindole (DAPI), for 5min. Finally, after several additional
PBS washes, the cover clips were mounted on glass slides, with
Prolong mounting medium (Molecular Probes, Eugene, OR, USA)
for fluorescence microscopy. Quantitative analysis of immuno-
fluorescence data was carried out with Image-Pros Plus software
(Media Cybernetics, Silver Spring, MD, USA).
Western blot analysis
Cell lysates were prepared in 2  Laemmli sample buffer,
containing 1% SDS and b-mercaptoethanol. After collecting
approximately 10
6 cells in 100ml of sample buffer, whole cell
lysates were boiled for 10min, cleared by centrifugation at 41C,
and stored at  801C until use. For SDS–polyacrylamide gel
electrophoresis, 20ml of the cleared lysates was loaded into a well
of the gel. Separated proteins were transferred onto an Immobilon-
P polyvinylidene fluoride membrane (Millipore, Bedford, MA,
USA). After tank transfer, membranes were blocked for 1h at room
temperature in 0.05% Tween 20-PBS (PBS-T) containing 5%,
nonfat dried milk, and then probed with primary antibody diluted
in PBS-T overnight in a 41C cold room. Antibodies and
concentrations were as follows: human c-Myc (9E10, 2mgml
 1;
14851A Pharmingen, San Diego, CA, USA), human p53 (PAb1801,
2.5mgml
 1; Ab-2 Oncogene Research Products, Boston, MA, USA),
p21/WAF1 (EA10, 1mgml
 1; Ab-1 Oncogene Research Products),
cyclin B1 (clone GNS1, 1mgml
 1; Ab-3 NeoMarkers, Fremont, CA,
USA), Cdc2/cdk1 (A17.1.1þPOH-1, 1mgml
 1; Ab-3 NeoMarkers),
and a-tubulin (DM1A, 1:1000 dilution; Ab-2 NeoMarkers). The
blots were then washed with PBS-T three times for 10min. All blots
were next incubated in Horse Radish Peroxidase-conjugated
secondary goat anti-mouse or anti-rabbit antibody (BioRad,
1:3000 dilution) for 1h at room temperature for chemilumines-
cent detection.
cDNA microarray analysis
For measuring changes in mRNA levels, following g-irradiation, we
used the Human Cell-cycle GEArrayt Q series kit (HS-001;
SuperArray Inc., Bethesda, MD, USA). Following the preparation
of total RNA with the Trizol
s reagent (Invitrogent/Life Technol-
ogies, Carlsbad, CA, USA), cDNA probes were synthesised and
hybridised to the GEArray membranes according to the provider’s
instructions. The hybridisation signals were digitised with
Phosphorimagert 445 SI (Molecular Dynamics, Sunnyvale, CA,
USA) and data were quantitated and analysed with ImageQuaNTt
software (Molecular Dynamics, Sunnyvale, CA, USA) and the
GEArray analyzert 1.2 software (SuperArray Inc., Bethesda, MD,
USA).
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